3D bioprinting stands poised to transform personalized medicine and regenerative therapies. Achieving this vision will require sustained, interdisciplinary efforts to refine printing methods, innovate bioink chemistry, and master tissue maturation.
Tiwari et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: